Safety and Efficacy of Long-term Somatropin Treatment in Adults
NCT01543880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 752
Last updated 2015-04-29
Summary
This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (Norditropin®).
Conditions
- Growth Hormone Disorder
- Adult Growth Hormone Deficiency
Interventions
- DRUG
-
somatropin
Prescribed at the discretion of the treating physician according to product labelling
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency
NCT01706783 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
NCT01009905 ·Status: COMPLETED
-
Safety and Efficacy of Long-term Somatropin Treatment in Children
NCT01543867 ·Status: COMPLETED
-
A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
NCT03075644 ·Status: COMPLETED ·Phase: PHASE3
-
Special Survey for Long Term Application
NCT01516229 ·Status: COMPLETED
-
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
NCT01401244 ·Status: COMPLETED ·Phase: PHASE1
-
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01604161 ·Status: COMPLETED
-
First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects
NCT01514500 ·Status: COMPLETED ·Phase: PHASE1
-
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
NCT00455884 ·Status: COMPLETED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
NCT00184652 ·Status: COMPLETED ·Phase: PHASE2
-
Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers
NCT01512095 ·Status: WITHDRAWN ·Phase: PHASE1
-
Use of Somatropin in Turner Syndrome
NCT01518036 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects
NCT00787878 ·Status: COMPLETED
-
Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency
NCT00191360 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
NCT00715689 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects
NCT03905850 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
NCT01110928 ·Status: COMPLETED
-
Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome
NCT01529840 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
NCT01943084 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 ·Status: COMPLETED ·Phase: PHASE3